Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study

European Respiratory Journal

Volumn 44, Issue 4, 2014, Pages 931-941

  Tkacova, Ruzena ^a,b   McNicholas, Walter T ^c   Javorsky, Martin ^a,b   Fietze, Ingo ^d   Sliwinski, Pawel ^e   Parati, Gianfranco ^f,g   Grote, Ludger ^h   Hedner, Jan ^h  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Dept of Diagnosis and Treatment of Respiratory Failure ^*  (Poland)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^h SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; AGE DISTRIBUTION; AGED; APNEA HYPOPNEA INDEX; ARTICLE; CARDIORESPIRATORY POLYGRAPHY; CHRONIC INTERMITTENT HYPOXIA; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EUROPE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICHANNEL RECORDER; OBESITY; OXYGEN DESATURATION; PATIENT REFERRAL; POLYSOMNOGRAPHY; PREDICTIVE VALUE; PREVALENCE; SEX RATIO; SLEEP DISORDERED BREATHING; SMOKING; VERY ELDERLY; ADOLESCENT; ANOXIA; COMPLICATION; FACTUAL DATABASE; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREVALENCE; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 84907501562     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00225113     Document Type: Article

References (46)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
2. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995; 8: 1161-1178.
3. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
4. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-1836.
5. Cano-Pumarega I, Duran-Cantolla J, Aizpuru F, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the Vitoria Sleep Cohort. Am J Respir Crit CareMed 2011; 184: 1299-1304.
6. OConnor GT, Caffo B, Newman AB, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009; 179: 1159-1164.
7. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-178.
8. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359: 204-210.
9. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
10. Marin JM, Carrizo SJ, Vicente E, et al. Long-Term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
11. Doherty LS, Kiely JL, Swan V, et al. Long-Term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-2084.
12. Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310: 2407-2415.
13. Foster GE, Brugniaux JV, Pialoux V, et al. Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans. J Physiol 2009; 587: 3287-3299.
14. Gilmartin GS, Lynch M, Tamisier R, et al. Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2010; 299: H925-H931.
15. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667.
16. Lavie L. Obstructive sleep apnoea syndrome-An oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
17. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996; 14: 577-584.
18. Kohler M, Stoewhas AC, Ayers L, et al. Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2011; 184: 1192-1199.
19. Hedner J, Ejnell H, Sellgren J, et al. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 1988; 6: S529-S531.
20. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-1752.
21. Hedner J, Grote L, Bonsignore M, et al. The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J 2011; 38: 635-642.
22. WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. 6th Edn. Oslo, World Health Organization, 2003.
23. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26: 1505-1526.
24. Ferber R, Millman R, Coppola M, et al. Portable recording in the assessment of obstructive sleep apnea. ASDA standards of practice. Sleep 1994; 17: 378-392.
25. Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM Manual for the Scoring of Sleep and Associated Events -Rules, Terminology and Technical Specifications. Westchester, American Academy of Sleep Medicine, 2007.
26. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
27. Paul P, Pennell ML, Lemeshow S. Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets. Stat Med 2013; 32: 67-80.
28. Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999; 160: 1875-1882.
29. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320: 479-482.
30. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000; 55: 736-740.
31. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19: 2271-2277.
32. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
33. Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997; 15: 1227-1233.
34. Roche F, Pepin JL, Achour-Crawford E, et al. At 68 years, unrecognised sleep apnoea is associated with elevated ambulatory blood pressure. Eur Respir J 2012; 40: 649-656.
35. Parati G, Lombardi C, Narkiewicz K. Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol 2007; 293: R1671-R1683.
36. Carlson JT, Hedner J, Elam M, et al. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103: 1763-1768.
37. Leuenberger U, Jacob E, Sweer L, et al. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995; 79: 581-588.
38. Ryan S, Ward S, Heneghan C, et al. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest 2007; 131: 1100-1107.
39. Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008; 32: 1488-1496.
40. Kohler M, Ayers L, Pepperell JC, et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009; 64: 67-73.
41. Fletcher EC. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001; 90: 1600-1605.
42. Foster GE, Hanly PJ, Ahmed SB, et al. Intermittent hypoxia increases arterial blood pressure in humans through a renin-Angiotensin system-dependent mechanism. Hypertension 2010; 56: 369-377.
43. Prabhakar NR, Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 2012; 92: 967-1003.
44. McNicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008; 5: 154-160.
45. Parati G, Omboni S, Bilo G. Why is out-of-office blood pressure measurement needed? Home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension 2009; 54: 181-187.
46. Parati G, Lombardi C, Hedner J, et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013; 41: 523-538.